共 50 条
[45]
Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-to-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study
[J].
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY,
2019, 143 (02)
:AB97-AB97
[50]
Dupilumab Reduces Oral Corticosteroid Use and Severe Exacerbations and Improves Lung Function in Patients With Oral Corticosteroid-Dependent Severe Asthma With and Without Comorbid Allergic Rhinitis in the Phase 3 LIBERTY ASTHMA VENTURE Study
[J].
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY,
2020, 145 (02)
:AB173-AB173